Anticorps anti-idiotypiques < Anticorps monoclonaux < Anticorps monoclonaux d'origine murine

Facettes : Author.f AffPays.f AffRegion.f AffVille.f AffOrg.f Mesh.f MeshFr.f Teeft.f

List of bibliographic references

Number of relevant bibliographic references: 37.
[20-40] [0 - 20][0 - 37]

Ident.	Authors (with country if any)	Title
000656 (2011)	Xavier Mariette [France] ; Jacques-Eric Gottenberg ; Philippe Ravaud ; Bernard Combe	Registries in rheumatoid arthritis and autoimmune diseases: data from the French registries.
000659 (2011)	Vincent André [France] ; Benoît Le Goff ; Christophe Leux ; Marianne Pot-Vaucel ; Yves Maugars ; Jean-Marie Berthelot	Information on glucocorticoid therapy in the main studies of biological agents.
000663 (2011)	Bernard Bannwarth [France] ; Christophe Richez	Clinical safety of tocilizumab in rheumatoid arthritis.
000698 (2011)	Christian Roux [France] ; Veronique Breuil [France] ; Christine Albert [France] ; Vacine Allam [France] ; Christian Grisot [France] ; Hasna Chami [France] ; Virginie Dasilva [France] ; Lianna Euller-Ziegler [France]	Ophthalmic Herpes Zoster Infection in Patients with Rheumatoid Arthritis Who Were Treated with Tocilizumab
000701 (2010)	Olivier Fain [France] ; Saad Rouaghe ; Jérôme Stirnemann	[Refractory adult-onset Still's disease].
000702 (2010)	B. Hansel [France] ; E. Bruckert	[Lipid profile and cardiovascular risk in patients with rheumatoid arthritis: Effect of the disease and of drug therapy].
000703 (2010)	Thao Pham [France] ; Pascal Claudepierre ; Arnaud Constantin ; Michel De Bandt ; Bruno Fautrel ; Laure Gossec ; Jacques-Eric Gottenberg ; Philippe Goupille ; Séverine Guillaume ; Eric Hachulla ; Charles Masson ; Jacques Morel ; Xavier Puéchal ; Alain Saraux ; Thierry Schaeverbeke ; Daniel Wendling ; Eric Bruckert ; Stanislas Pol ; Xavier Mariette ; Jean Sibilia	Tocilizumab: therapy and safety management.
000705 (2010)	Eric Assier [France] ; Marie-Christophe Boissier ; Jean-Michel Dayer	Interleukin-6: from identification of the cytokine to development of targeted treatments.
000706 (2010)	Jun Hashimoto [Japon] ; Patrick Garnero [France] ; Désirée Van Der Heijde [Pays-Bas] ; Nobuyuki Miyasaka [Japon] ; Kazuhiko Yamamoto [Japon] ; Shinichi Kawai [Japon] ; Tsutomu Takeuchi [Japon] ; Hideki Yoshikawa [Japon] ; Norihiro Nishimoto [Japon]	Humanized anti-interleukin-6-receptor antibody (tocilizumab) monotherapy is more effective in slowing radiographic progression in patients with rheumatoid arthritis at high baseline risk for structural damage evaluated with levels of biomarkers, radiography, and BMI: data from the SAMURAI study
000707 (2010)	Pierre Quartier [France]	Current treatments for juvenile idiopathic arthritis.
000715 (2010)	S. Laurent ; J. Le Parc ; T. Clérici ; M. Bréban ; E. Mahé [France]	Onset of psoriasis following treatment with tocilizumab
000725 (2010)	Patrick Garnero [France] ; Elizabeth Thompson [Royaume-Uni] ; Thasia Woodworth [Royaume-Uni] ; Josef S. Smolen [Autriche]	Rapid and Sustained Improvement in Bone and Cartilage Turnover Markers With the Anti-Interleukin-6 Receptor Inhibitor Tocilizumab Plus Methotrexate in Rheumatoid Arthritis Patients With an Inadequate Response to Methotrexate: Results From a Substudy of the Multicenter Double-Blind, Placebo-Controlled Trial of Tocilizumab in Inadequate Responders to Methotrexate Alone
000730 (2009)	M. De Bandt [France] ; B. Saint-Marcoux [France]	Tocilizumab for multirefractory adult-onset Still’s disease
000736 (2008)	Bruno Fautrel [France]	Adult-onset Still disease.
000737 (2008)	P. Emery [Royaume-Uni] ; E. Keystone [Canada] ; H P Tony [Allemagne] ; A. Cantagrel [France] ; R. Van Vollenhoven [Suède] ; A. Sanchez [Mexique] ; E. Alecock [Royaume-Uni] ; J. Lee [États-Unis] ; J. Kremer [États-Unis]	IL-6 receptor inhibition with tocilizumab improves treatment outcomes in patients with rheumatoid arthritis refractory to anti-tumour necrosis factor biologicals: results from a 24-week multicentre randomised placebo-controlled trial
000740 (2007)	Jagadeesh Bayry [France] ; Sébastien Lacroix-Desmazes ; Michel D. Kazatchkine ; Srini V. Kaveri	Monoclonal antibody and intravenous immunoglobulin therapy for rheumatic diseases: rationale and mechanisms of action.
000741 (2005)	Patricia Woo [Royaume-Uni] ; Nicholas Wilkinson [Royaume-Uni] ; Anne-Marie Prieur [France] ; Taunton Southwood [Royaume-Uni] ; Valentina Leone [Royaume-Uni] ; Polly Livermore [Royaume-Uni] ; Helena Wythe [Royaume-Uni] ; David Thomson [Royaume-Uni] ; Tadamitsu Kishimoto [Japon]	Open label phase II trial of single, ascending doses of MRA in Caucasian children with severe systemic juvenile idiopathic arthritis: proof of principle of the efficacy of IL-6 receptor blockade in this type of arthritis and demonstration of prolonged clinical improvement

---

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Sante/explor/TocilizumabV1/Data/France/Analysis

HfdIndexSelect -h $EXPLOR_AREA/Data/France/Analysis/MeshFr.i -k "Anticorps monoclonaux" 

HfdIndexSelect -h $EXPLOR_AREA/Data/France/Analysis/MeshFr.i  \
                -Sk "Anticorps monoclonaux" \
         | HfdSelect -Kh $EXPLOR_AREA/Data/France/Analysis/biblio.hfd 

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Sante
   |area=    TocilizumabV1
   |flux=    France
   |étape=   Analysis
   |type=    indexItem
   |index=    MeshFr.i
   |clé=    Anticorps monoclonaux
}}

---

This area was generated with Dilib version V0.6.34. Data generation: Fri May 22 09:34:00 2020. Site generation: Sun Mar 28 09:01:19 2021